Approval · Notice of Compliance 1033 · 2000
ACTINAC: Notice of Compliance 1033
Issued September 27, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1033
- Date
- September 27, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Topical anti-acne
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTINAC | 02224542 | — |
Medicinal ingredients
- ALLANTOIN 24 MG per G
- CHLORAMPHENICOL 40 MG per G
- HYDROCORTISONE ACETATE 40 MG per G
- SULFUR 320 MG per G
- BUTOXYETHYLNICOTINATE 24 MG per G